Abbott Laboratories Balance Sheet Health
Financial Health criteria checks 6/6
Abbott Laboratories has a total shareholder equity of $38.8B and total debt of $15.9B, which brings its debt-to-equity ratio to 40.9%. Its total assets and total liabilities are $73.2B and $34.4B respectively. Abbott Laboratories's EBIT is $7.1B making its interest coverage ratio 27.2. It has cash and short-term investments of $7.3B.
Key information
40.9%
Debt to equity ratio
US$15.87b
Debt
Interest coverage ratio | 27.2x |
Cash | US$7.28b |
Equity | US$38.83b |
Total liabilities | US$34.39b |
Total assets | US$73.21b |
Recent financial health updates
No updates
Recent updates
Financial Position Analysis
Short Term Liabilities: ABL's short term assets ($22.7B) exceed its short term liabilities ($13.8B).
Long Term Liabilities: ABL's short term assets ($22.7B) exceed its long term liabilities ($20.5B).
Debt to Equity History and Analysis
Debt Level: ABL's net debt to equity ratio (22.1%) is considered satisfactory.
Reducing Debt: ABL's debt to equity ratio has reduced from 61.4% to 40.9% over the past 5 years.
Debt Coverage: ABL's debt is well covered by operating cash flow (45.7%).
Interest Coverage: ABL's interest payments on its debt are well covered by EBIT (27.2x coverage).